Cargando…

Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease

AIM: To validate the effects of receptor interacting protein kinase-3 (RIP3) deletion in non-alcoholic fatty liver disease (NAFLD) and to clarify the mechanism of action. METHODS: Wild-type (WT) and RIP3 knockout (KO) mice were fed normal chow and high fat (HF) diets for 12 wk. The body weight was a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saeed, Waqar Khalid, Jun, Dae Won, Jang, Kiseok, Ahn, Sang Bong, Oh, Ju Hee, Chae, Yeon Ji, Lee, Jai Sun, Kang, Hyeon Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319133/ https://www.ncbi.nlm.nih.gov/pubmed/30622377 http://dx.doi.org/10.3748/wjg.v24.i48.5477

Ejemplares similares

Granulocyte colony stimulating factor treatment in non-alcoholic fatty liver disease: beyond marrow cell mobilization
por: Nam, Ho Hyun, et al.
Publicado: (2017)

Feasibility and Stability of Liver Biopsy before Treatment for Preclinical Nonalcoholic Fatty Liver Studies
por: Chae, Yeon Ji, et al.
Publicado: (2019)

The Use of Foxa2-Overexpressing Adipose Tissue-Derived Stem Cells in a Scaffold System Attenuates Acute Liver Injury
por: Chae, Yeon Ji, et al.
Publicado: (2019)

Does necroptosis have a crucial role in hepatic ischemia-reperfusion injury?
por: Saeed, Waqar K., et al.
Publicado: (2017)

Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
por: Lee, Hyo Young, et al.
Publicado: (2019)

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
por: Oh, Hyunwoo, et al.
Publicado: (2016)

Optimal Hypoxic Preconditioning of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells (hES-MSCs) and Their Characteristics
por: Lee, Seung Min, et al.
Publicado: (2021)

Duodenal Niemann-Pick C1-like 1 expression was negatively correlated with liver X receptor expression in nonalcoholic fatty liver disease
por: Ahn, Sang Bong, et al.
Publicado: (2019)

Changes in human hepatic metabolism in steatosis and cirrhosis
por: Schofield, Zoe, et al.
Publicado: (2017)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
por: Ahn, Sang Bong
Publicado: (2023)

Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice
por: Fan, Jing, et al.
Publicado: (2019)

Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver
por: Schneider, Ana Claudia Reis, et al.
Publicado: (2017)

Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat
por: Jiang, Wei, et al.
Publicado: (2016)

circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling
por: Guo, Xing-Ya, et al.
Publicado: (2018)

Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease
por: Kostrzewski, Tomasz, et al.
Publicado: (2017)

Fractionation of gamma-glutamyltransferase in patients with nonalcoholic fatty liver disease and alcoholic liver disease
por: Sueyoshi, Shigeo, et al.
Publicado: (2016)

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
por: Leung, Christopher, et al.
Publicado: (2016)

Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
por: Shepherd, Emma L, et al.
Publicado: (2020)

Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease
por: Ahn, Jem Ma, et al.
Publicado: (2016)

Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease
por: Yang, Jia-Min, et al.
Publicado: (2019)

Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats
por: Tan, Yi, et al.
Publicado: (2017)

Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe(-/-) mice
por: Heritage, Mandy, et al.
Publicado: (2017)

Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling
por: Suga, Takayoshi, et al.
Publicado: (2020)

Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways
por: Lee, Seung Min, et al.
Publicado: (2022)

Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence
por: Melton, Phillip E., et al.
Publicado: (2023)

A survey on the awareness, current management, and barriers for non-alcoholic fatty liver disease among the general Korean population
por: Lee, Jun-Hyuk, et al.
Publicado: (2023)

New Era for Usage of Serum Liver Enzymes as A Promising Horizon for the Prediction of Non-Alcoholic Fatty Liver Disease
por: Salman, Ahmed Abd Allah, et al.
Publicado: (2016)

Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice
por: Velázquez, Kandy T, et al.
Publicado: (2019)

Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis
por: Takayama, Shun, et al.
Publicado: (2021)

Fibrosis in Chronic Hepatitis C: Correlation between Immunohistochemically-Assessed Virus Load with Steatosis and Cellular Iron Content
por: Akl, Maha, et al.
Publicado: (2016)

Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease
por: Kapil, Shweta, et al.
Publicado: (2016)

miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1
por: Liu, Xiao-Lin, et al.
Publicado: (2017)

Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression
por: Deenin, Wanwisa, et al.
Publicado: (2021)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism
por: He, Miao, et al.
Publicado: (2020)

Alcohol and Steatosis: The Japanese Paradox
por: Lonardo, A., et al.
Publicado: (2016)

Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease
por: Zhu, Feng, et al.
Publicado: (2019)

Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α
por: Liu, Ting, et al.
Publicado: (2019)

Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits
por: Xing, Ya-Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8ong3773s4hld8d0hqkmnkbta7